ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Data On CT Screening For Lung Cancer Raises Questions About DOD Program

April 23, 2010

Pooled Analysis of 12 Seperate Yervoy Studies Shows Survival-Curve Plateau at 3 Years

October 25, 2013

Kimes, Lenfant, To Retire

July 11, 2003